These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35937937)

  • 21. Comparison of digene hybrid capture 2, GeneMatrix PapilloScreen, and a PCR sequencing assay in detecting high-risk and probable high-risk oncogenic HPV genotypes in specimens from Korean women.
    Bae JM; Min KT; Shin JY; Shin SK; Kim SN; Lee HP; Kim SO; Hong SP
    Arch Virol; 2014 Aug; 159(8):1909-16. PubMed ID: 24562428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
    Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M
    J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical performance of newly developed multiplex human papillomavirus genotyping assay using Luminex xMAP™ technology (Mebgen™ HPV Kit).
    Ozaki S; Kato K; Abe Y; Hara H; Kubota H; Kubushiro K; Kawahara E; Inoue M
    J Virol Methods; 2014 Aug; 204():73-80. PubMed ID: 24768623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
    van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
    J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping.
    Lim YK; Choi JH; Park S; Kweon OJ; Park AJ
    J Clin Lab Anal; 2016 Nov; 30(6):1110-1115. PubMed ID: 27121347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
    APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a novel real-time fluorescent polymerase chain reaction assay for high-risk human papilloma virus DNA genotypes in cytological cervical screening.
    Cheng J; Bian M; Cong X; Sun A; Li M; Ma L; Chen Y; Liu J
    Biomed Rep; 2013 Mar; 1(2):280-284. PubMed ID: 24648936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.
    Zhang L; Dai Y; Chen J; Hong L; Liu Y; Ke Q; Chen Y; Cai C; Liu X; Chen Z
    J Med Virol; 2018 Jan; 90(1):177-183. PubMed ID: 28851089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY; Kim H; Park KH
    Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
    Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
    J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea.
    So KA; Hong JH; Lee JK
    J Cancer Prev; 2016 Jun; 21(2):104-9. PubMed ID: 27390739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media.
    Min KJ; So KA; Lee J; Hong HR; Hong JH; Lee JK; Kim AR
    J Gynecol Oncol; 2012 Jan; 23(1):5-10. PubMed ID: 22355460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
    Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
    J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples.
    Wang HY; Kim H; Park S; Park KH; Lee H
    Exp Mol Pathol; 2019 Feb; 106():149-156. PubMed ID: 30605636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical performance of two high-throughput liquid bead microarray assays, GeneFinder and CareGENE, for cervical screening in the general population.
    Moon JH; Jeong K; Kim K; Lee C; Jin MS; Ryu HS
    Arch Virol; 2019 Nov; 164(11):2699-2706. PubMed ID: 31435867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework.
    Dhillon SK; Oštrbenk Valenčak A; Xu L; Poljak M; Arbyn M
    J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33731413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.